Information:
Fel:
ID
39685
Beskrivning
Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT- 267 (ABT-450/r/ABT-267) in Japanese Adults With Subgenotype 1b Chronic Hepatitis C Virus (HCV) Infection; ODM derived from: https://clinicaltrials.gov/show/NCT02023099
Länk
https://clinicaltrials.gov/show/NCT02023099
Nyckelord
Versioner (1)
- 2020-02-10 2020-02-10 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
10 februari 2020
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Hepatitis C Virus NCT02023099
Eligibility Hepatitis C Virus NCT02023099
- StudyEvent: Eligibility
Similar models
Eligibility Hepatitis C Virus NCT02023099
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Hepatitis C, Chronic
Item
chronic hcv-infection prior to study enrollment
boolean
C0524910 (UMLS CUI [1])
Laboratory Results | Indication Hepatitis C Genotype
Item
screening laboratory result indicating hcv subgenotype 1b infection
boolean
C1254595 (UMLS CUI [1])
C3146298 (UMLS CUI [2,1])
C0019196 (UMLS CUI [2,2])
C1533728 (UMLS CUI [2,3])
C3146298 (UMLS CUI [2,1])
C0019196 (UMLS CUI [2,2])
C1533728 (UMLS CUI [2,3])
Hepatitis C virus RNA assay Plasma
Item
subject has plasma hcv rna level greater than 10,000 iu/ml at screening
boolean
C1272251 (UMLS CUI [1,1])
C0032105 (UMLS CUI [1,2])
C0032105 (UMLS CUI [1,2])
Informed Consent
Item
voluntarily sign an informed consent
boolean
C0021430 (UMLS CUI [1])
HBV coinfection | HIV coinfection | HCV coinfection Genotype | Exception Genotype
Item
co-infection of hepatitis b virus (hbv), hiv and any hcv genotype other than subgenotype 1b
boolean
C2242656 (UMLS CUI [1])
C4062778 (UMLS CUI [2])
C1698259 (UMLS CUI [3,1])
C1533728 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C1533728 (UMLS CUI [4,2])
C4062778 (UMLS CUI [2])
C1698259 (UMLS CUI [3,1])
C1533728 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C1533728 (UMLS CUI [4,2])
Prior Therapy Hepatitis C | DIRECT ACTING ANTIVIRALS | telaprevir | simeprevir | boceprevir
Item
prior therapy with direct acting antiviral agents for the treatment of hcv, including telaprevir, simeprevir and boceprevir
boolean
C1514463 (UMLS CUI [1,1])
C0019196 (UMLS CUI [1,2])
C3653501 (UMLS CUI [2])
C1876229 (UMLS CUI [3])
C2605855 (UMLS CUI [4])
C1738934 (UMLS CUI [5])
C0019196 (UMLS CUI [1,2])
C3653501 (UMLS CUI [2])
C1876229 (UMLS CUI [3])
C2605855 (UMLS CUI [4])
C1738934 (UMLS CUI [5])
Liver disease | Etiology Except Chronic Hepatitis C
Item
any cause of liver disease other than chronic hcv-infection, including but not limited to the following:
boolean
C0023895 (UMLS CUI [1])
C0015127 (UMLS CUI [2,1])
C0332300 (UMLS CUI [2,2])
C0524910 (UMLS CUI [2,3])
C0015127 (UMLS CUI [2,1])
C0332300 (UMLS CUI [2,2])
C0524910 (UMLS CUI [2,3])
Hemochromatosis
Item
hemochromatosis
boolean
C0018995 (UMLS CUI [1])
Alpha-1 Antitrypsin Deficiency
Item
alpha-1 antitrypsin deficiency
boolean
C0221757 (UMLS CUI [1])
Hepatolenticular Degeneration
Item
wilson's disease
boolean
C0019202 (UMLS CUI [1])
Hepatitis, Autoimmune
Item
autoimmune hepatitis
boolean
C0241910 (UMLS CUI [1])
Alcoholic Liver Disease
Item
alcoholic liver disease
boolean
C0023896 (UMLS CUI [1])
Drug-Induced Liver Disease
Item
drug-related liver disease
boolean
C0860207 (UMLS CUI [1])
Laboratory test result abnormal
Item
clinically significant laboratory abnormalities
boolean
C0438215 (UMLS CUI [1])
Disease Uncontrolled
Item
uncontrolled clinically significant disease, disorder or medical illness
boolean
C0012634 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0205318 (UMLS CUI [1,2])